173 related articles for article (PubMed ID: 10687142)
1. Cytokine-inducing activity and antitumor effect of a liposome-incorporated interferon-gamma-inducing molecule derived from OK-432, a streptococcal preparation.
Okamoto M; Gohda H; Ohe G; Yoshida H; Matsuno T; Saito M; Sato M
J Immunother; 2000 Jan; 23(1):94-103. PubMed ID: 10687142
[TBL] [Abstract][Full Text] [Related]
2. Induction of Th1-type cytokines by lipoteichoic acid-related preparation isolated from OK-432, a penicillin-killed streptococcal agent.
Okamoto M; Ohe G; Oshikawa T; Nishikawa H; Furuichi S; Yoshida H; Matsuno T; Saito M; Sato M
Immunopharmacology; 2000 Sep; 49(3):363-76. PubMed ID: 10996034
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of anti-tumor immunity by lipoteichoic acid-related molecule isolated from OK-432, a streptococcal agent, in athymic nude mice bearing human salivary adenocarcinoma: role of natural killer cells.
Okamoto M; Ohe G; Furuichi S; Nishikawa H; Oshikawa T; Tano T; Ahmed SU; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
Anticancer Res; 2002; 22(6A):3229-39. PubMed ID: 12530069
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of interferon-gamma-inducing molecule of OK-432, a penicillin-killed streptococcal preparation, by monoclonal antibody neutralizing interferon-gamma-inducing activity of OK-432.
Okamoto M; Kaji R; Kasetani H; Yoshida H; Moriya Y; Saito M; Sato M
J Immunother Emphasis Tumor Immunol; 1993 May; 13(4):232-42. PubMed ID: 8334107
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of anti-cancer immunity by a lipoteichoic-acid-related molecule isolated from a penicillin-killed group A Streptococcus.
Okamoto M; Ohe G; Oshikawa T; Furuichi S; Nishikawa H; Tano T; Ahmed SU; Yoshida H; Moriya Y; Saito M; Sato M
Cancer Immunol Immunother; 2001 Oct; 50(8):408-16. PubMed ID: 11726135
[TBL] [Abstract][Full Text] [Related]
6. cis-Diamminedichloroplatinum and 5-fluorouracil are potent inducers of the cytokines and natural killer cell activity in vivo and in vitro.
Okamoto M; Kasetani H; Kaji R; Goda H; Ohe G; Yoshida H; Sato M
Cancer Immunol Immunother; 1998 Dec; 47(4):233-41. PubMed ID: 9875677
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-gamma-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction.
Oshikawa T; Okamoto M; Ohe G; Furuichi S; Nishikawa H; Uddin Ahmed S; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
Int Immunopharmacol; 2003 May; 3(5):643-55. PubMed ID: 12757734
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody to a human salivary gland adenocarcinoma cell line: augmentation of antibody-dependent cell-mediated cytotoxicity activity by streptococcal preparation OK-432 in human salivary gland adenocarcinoma-bearing nude mice given the antibody.
Kaji R; Yoshida H; Yanagawa T; Sato M
J Biol Response Mod; 1989 Oct; 8(5):488-500. PubMed ID: 2552025
[TBL] [Abstract][Full Text] [Related]
9. Analysis of antitumor effects of OK-432 against syngeneic mouse fibrosarcoma: combination effect of OK-432 and recombinant lymphokines.
Nanjo M; Moriya Y; Hashimoto S; Kataoka M; Saito M; Yoshida T; Ishida N
Int J Immunopharmacol; 1991; 13(2-3):205-15. PubMed ID: 1906439
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody to the streptococcal preparation OK-432: tissue OK-432 localization and analysis of interaction between OK-432 and macrophages or NK cells in human salivary adenocarcinoma-bearing nude mice given OK-432.
Sato M; Kaji R; Urata M; Yoshida H; Yanagawa T; Miyamoto K; Azuma M; Furumoto N; Saito M
J Biol Response Mod; 1988 Apr; 7(2):212-28. PubMed ID: 3361352
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cytokine-inducing activity in a lipoteichoic acid-related molecule isolated from a penicillin-killed group A Streptococcus and from untreated bacteria.
Okamoto M; Oshikawa T; Ohe G; Furuichi S; Nishikawa H; Tano T; Bando T; Yoshida H; Matsubara S; Matsuno T; Saito M; Sato M
Int Immunopharmacol; 2001 Oct; 1(11):1957-68. PubMed ID: 11606027
[TBL] [Abstract][Full Text] [Related]
12. Severe impairment of anti-cancer effect of lipoteichoic acid-related molecule isolated from a penicillin-killed Streptococcus pyogenes in toll-like receptor 4-deficient mice.
Okamoto M; Oshikawa T; Ohe G; Nishikawa H; Furuichi S; Tano T; Moriya Y; Saito M; Sato M
Int Immunopharmacol; 2001 Sep; 1(9-10):1789-95. PubMed ID: 11562070
[TBL] [Abstract][Full Text] [Related]
13. Effect of streptococcal lyzate OK-432 on peripheral blood mononuclear cells in gastric cancer patients.
Nakayama F; Iwagaki H; Gouchi A; Hizuta A; Isozaki H; Takakura N; Tanaka N
J Med; 1998; 29(3-4):199-215. PubMed ID: 9865458
[TBL] [Abstract][Full Text] [Related]
14. Generation of activated killer-like cells by OK-432-mediated production of interleukin 1, interleukin 2, and interferon-gamma in vitro.
Ujiie T
Jpn J Exp Med; 1987 Dec; 57(6):333-8. PubMed ID: 3131563
[TBL] [Abstract][Full Text] [Related]
15. Induction of inflammatory cytokines in effusion cavity by OK-432 injection therapy for patients with malignant effusion: role of interferon-gamma in enhancement of surface expression of ICAM-1 on tumor cells in vivo.
Kitsuki H; Katano M; Ikubo A; Morisaki T; Anann K; Tanaka M; Torisu M
Clin Immunol Immunopathol; 1996 Mar; 78(3):283-90. PubMed ID: 8605704
[TBL] [Abstract][Full Text] [Related]
16. Role of interleukin-2 and interferon-gamma in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.
Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K; Kuribayashi K; Saito K
Cancer Immunol Immunother; 1989; 29(2):79-86. PubMed ID: 2497980
[TBL] [Abstract][Full Text] [Related]
17. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha.
Hunter CA; Subauste CS; Van Cleave VH; Remington JS
Infect Immun; 1994 Jul; 62(7):2818-24. PubMed ID: 7911785
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of LAK-like activity and cytokine induction in regional lymph nodes and spleen cells of mice after intralymphnodal injection of OK-432, a killed streptococcal preparation.
Sakakura C; Takahashi T; Hagiwara A; Yamane T; Sawai S; Okano S; Ozaki K; Sasaki S; Tsujimoto H
Anticancer Drugs; 1993 Jun; 4(3):381-8. PubMed ID: 8358067
[TBL] [Abstract][Full Text] [Related]
19. In vivo antitumor effects of murine interferon-gamma-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites.
Micallef MJ; Yoshida K; Kawai S; Hanaya T; Kohno K; Arai S; Tanimoto T; Torigoe K; Fujii M; Ikeda M; Kurimoto M
Cancer Immunol Immunother; 1997 Jan; 43(6):361-7. PubMed ID: 9067408
[TBL] [Abstract][Full Text] [Related]
20. Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state.
Fujimoto T; Duda RB; Szilvasi A; Chen X; Mai M; O'Donnell MA
J Immunol; 1997 Jun; 158(12):5619-26. PubMed ID: 9190909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]